Medrobotics Corp., a Raynham-based medical robotics company, announced Thursday the conversion of notes totaling $33.6 million purchased through recent financings into Series D Preferred Stock.

Existing Medrobotics shareholders and undisclosed new investors participated in the Series D raise., the company said in a press release.